ERBP - News
As a response to the earthquake disaster in Nepal, the team of prof Vivekanand Jha and Dr Oommen John are producing an application to make the short version of the Crush guideline of ERBP - RDTRF available on mobile devices (laptops, smartphones, tablets). This app will be soon available at iTunes and Googleplay. You can already have a pre-view of how it will look at:
Identifying high priority topics for Management of frail and elderly patients with Chronic Kidney Disease. A mutual agreement between nephrologists and geriatricians?
Ionut Nistor, MD
Translated Field version available in
Nephrologists see a growing number of frail and elderly in their practice nowadays. This increases their need for guidance on how to provide care to frail kidney patients, including withdrawal of dialysis and on palliative care after the actual withdrawal.
Results Peer review ERPB Transplant Guideline
Our peer review of the new transplant guideline: "ERBP guideline on donor and recipient evaluation and peri-operative care" has been a great success.
648 members of ERA-EDTA, of which 27 also belong to the Descartes group, have sent a reply and completed the SurveyMonkey questionnaire.
Over the last two years, a working group of European Renal Best Practice (ERBP) has established a guideline concerning the evaluation and preparation of donor and recipient of a kidney transplant, in the pre-transplantation and peri-operative period.
We have now finalized this interesting process, which, as you can imagine, was hard work for all members of the group.
On the occasion of the launch of the guideline "Management of Hyponatraemia", the ERA-EDTA, European Renal Best Practice, European Society of Endocrinology and the European Society of Intensive Care Medicine co-organise a CME session entitled: "Hyponatraemia: an Evidence Based Approach"
The prevalence of major depression in stage 5 chronic kidney disease (CKD) is high. Patients with CKD who are depressed have a worse quality of life, are hospitalized more often and die sooner than those who are not depressed. Antidepressant drugs are effective in the general population, but whether they improve outcomes in CKD is uncertain.